![JPS vt-x7 treatment.jpg](https://static.wixstatic.com/media/76c860_aac88184924641ffa05fcb398faac40d~mv2.jpg/v1/fill/w_980,h_351,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/76c860_aac88184924641ffa05fcb398faac40d~mv2.jpg)
Pipeline Overview
Pipeline Overview
![](https://static.wixstatic.com/media/1b555c_8f7310f40c3844e48b9b638e63bacf49~mv2.png/v1/fill/w_200,h_61,al_c,q_95,enc_avif,quality_auto/1b555c_8f7310f40c3844e48b9b638e63bacf49~mv2.png)
![Beaubien.jpg](https://static.wixstatic.com/media/1b555c_f30fdd2e69fa42198f6ad6d341e39341~mv2.jpg/v1/fill/w_312,h_312,al_c,q_90,enc_avif,quality_auto/Beaubien.jpg)
Brian deBeaubien, M.D.
Chief Medical Officer
Dr. de Beaubien is certified by the American Board of Orthopedic Surgery and is a Fellow of the American Association of Orthopedic Surgeons (AAOS), and American Association of Hip and Knee Surgeons (AAHKS). He graduated Magna Cum Laude from Alma College (‘85) as a member of Phi Beta Kappa and went on to earn his M.D. degree with High Distinction from Wayne State University (Detroit), as a member of Alpha Omega Alpha. Orthopedic residency was completed in Grand Rapids, Michigan followed by a fellowship in adult reconstructive surgery at Providence Hospital in Seattle.
With a career spanning over 25 years in clinical practice,
Dr de Beaubien has focused on one of the most challenging and devastating problems in total joint surgery; peri-prosthetic joint infection (PJI). As founder of Osteal Therapeutics, he has multiple issued patents for a novel intra-articular antibiotic drug delivery system for rapid, reliable treatment of periprosthetic joint infections.